Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2018

Open Access 01-12-2018 | Primary Research

Alteration of metabolite profiling by cold atmospheric plasma treatment in human myeloma cells

Authors: Dehui Xu, Yujing Xu, Ning Ning, Qingjie Cui, Zhijie Liu, Xiaohua Wang, Dingxin Liu, Hailan Chen, Michael G. Kong

Published in: Cancer Cell International | Issue 1/2018

Login to get access

Abstract

Background

Despite new progress of chemotherapy in multiple myeloma (MM) clinical treatment, MM is still a refractory disease and new technology is needed to improve the outcomes and prolong the survival. Cold atmospheric plasma is a rapidly developed technology in recent years, which has been widely applied in biomedicine. Although plasma could efficiently inactivate various tumor cells, the effects of plasma on tumor cell metabolism have not been studied yet.

Methods

In this study, we investigated the metabolite profiling of He plasma treatment on myeloma tumor cells by gas-chromatography time-of-flight (GC-TOF) mass-spectrometry. Meanwhile, by bioinformatic analysis such as GO and KEGG analysis we try to figure out the metabolism pathway that was significantly affected by gas plasma treatment.

Results

By GC-TOF mass-spectrometry, 573 signals were detected and evaluated using PCA and OPLS-DA. By KEGG analysis we listed all the differential metabolites and further classified into different metabolic pathways. The results showed that beta-alanine metabolism pathway was the most significant change after He gas plasma treatment in myeloma cells. Besides, propanoate metabolism and linoleic acid metabolism should also be concerned during gas plasma treatment of cancer cells.

Conclusions

Cold atmospheric plasma treatment could significantly alter the metabolite profiling of myeloma tumor cells, among which, the beta-alanine metabolism pathway is the most susceptible to He gas plasma treatment.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;80:101–19.CrossRef
4.
Krishnan SR, Jaiswal R, Brown RD, Luk F, Bebawy M. Multiple myeloma and persistence of drug resistance in the age of novel drugs. Int J Oncol. 2016;49:33–50.CrossRefPubMed
5.
Podar K, Chauhan D, Anderson KC. Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia. 2009;23:10–24.CrossRefPubMed
6.
Armoiry X, Tsertsvadze A, Connock M, Melendez-Torres G, Clarke A. Systematic review and network meta-analysis of treatment outcomes for multiple myeloma. J Clin Oncol. 2017;35:2975–6.CrossRefPubMed
7.
Malard F, Harousseau J, Mohty M. Multiple myeloma treatment at relapse after autologous stem cell transplantation: a practical analysis. Cancer Treat Rev. 2017;52:41–7.CrossRefPubMed
8.
Graves DB. Reactive species from cold atmospheric plasma: implications for cancer therapy. Plasma Process Polym. 2014;11:1120–7.CrossRef
9.
Keidar M, Shashurin A, Volotskova O, et al. Cold atmospheric plasma in cancer therapy. Phys Plasmas. 2013;20:057101.CrossRef
10.
Kvam E, Davis B, Mondello F, Garner AL. Nonthermal atmospheric plasma rapidly disinfects multidrug-resistant microbes by inducing cell surface damage. Antimicrob Agents chemother. 2012;56:2028–36.CrossRefPubMedPubMedCentral
11.
Gurol C, Ekinci FY, Aslan N, Korachi M. Low temperature plasma for decontamination of E. coli in milk. Int J Food Microbiol. 2012;157:1–5.CrossRefPubMed
12.
Keidar M, Walk R, Shashurin A, et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer. 2011;105:1295–301.CrossRefPubMedPubMedCentral
13.
Isbary G, Morfill G, Schmidt HU, et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol. 2010;163:78–82.PubMed
14.
Ishaq M, Evans M, Ostrikov K. Effect of atmospheric gas plasmas on cancer cell signaling. Int J Cancer. 2014;134:1517–28.CrossRefPubMed
15.
Kalghatgi SU, Fridman G, Cooper M, et al. Mechanism of blood coagulation by nonthermal atmospheric pressure dielectric barrier discharge plasma. IEEE Trans Plasma Sci. 2007;35:1559–66.CrossRef
16.
Fridman G, Friedman G, Gutsol A, et al. Applied plasma medicine. Plasma Process Polym. 2008;5:503–33.CrossRef
17.
18.
Zhang X, Li M, Zhou R, Feng K, Yang S. Ablation of liver cancer cells in vitro by a plasma needle. Appl Phys Lett. 2008;93:021502.CrossRef
19.
Thiyagarajan M, Sarani A, Gonzales XF. Characterization of an atmospheric pressure plasma jet and its applications for disinfection and cancer treatment. Stud Health Technol Inform. 2013;184:443–9.PubMed
20.
21.
Yan X, Zou F, Zhao S, et al. On the mechanism of plasma inducing cell apoptosis. IEEE Trans Plasma Sci. 2010;38:2451–7.CrossRef
22.
Vandamme M, Robert E, Pesnel S, et al. Antitumor effect of plasma treatment on U87 glioma xenografts: preliminary results. Plasma Process Polym. 2010;38:748–57.
23.
Brulle L, Vandamme M, Ries D, et al. Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model. PLoS ONE. 2012;7:e52653.CrossRefPubMedPubMedCentral
24.
Ahn HJ, Kim KI, Kim G, et al. Atmospheric-pressure plasma jet induces apoptosis involving mitochondria via generation of free radicals. PLoS ONE. 2011;6:e28154.CrossRefPubMedPubMedCentral
25.
Majumdar A, Ummanni R, Schroder K, Walther R, Hippler R. Cancer cells (MCF-7, Colo-357, and LNCaP) viability on amorphous hydrogenated carbon nitride film deposited by dielectric barrier discharge plasma. J Appl Phys. 2009;106:034702.CrossRef
26.
Min Joh H, Ja Kim S, Chung T, Leem S. Reactive oxygen species-related plasma effects on the apoptosis of human bladder cancer cells in atmospheric pressure pulsed plasma jets. Appl Phys Lett. 2012;101:053703.CrossRef
27.
Walk RM, Snyder JA, Srinivasan P, et al. Cold atmospheric plasma for the ablative treatment of neuroblastoma. J Pediatr Surg. 2013;48:67–73.CrossRefPubMed
28.
Xu D, Luo X, Xu Y, et al. The effects of cold atmospheric plasma on cell adhesion, differentiation, migration, apoptosis and drug sensitivity of multiple myeloma. Biochem Biophys Res Commun. 2016;473:1125–32.CrossRefPubMed
29.
Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell. 2008;13:472–82.CrossRefPubMed
30.
Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85–95.CrossRefPubMed
31.
32.
Xu D, Liu D, Wang B, et al. In situ OH generation from O2 − and H2O2 plays a critical role in plasma-induced cell death. PLoS ONE. 2015;10:e0128205.CrossRefPubMedPubMedCentral
33.
Mayevsky A. Mitochondrial function and energy metabolism in cancer cells: past overview and future perspectives. Mitochondrion. 2009;9:165–79.CrossRefPubMed
34.
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–33.CrossRefPubMedPubMedCentral
35.
36.
Bylesjö M, Rantalainen M, Cloarec O, et al. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom. 2006;20:341–51.CrossRef
37.
Meyer TE, Fox SD, Issaq HJ, et al. A reproducible and high-throughput HPLC/MS method to separate sarcosine from α-and β-alanine and to quantify sarcosine in human serum and urine. Anal Chem. 2011;83:5735–40.CrossRefPubMed
38.
Fernie AR, Carrari F, Sweetlove LJ. Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport. Curr Opin Plant Biol. 2004;7:254–61.CrossRefPubMed
39.
Hutschenreuther A, Birkenmeier G, Bigl M, Krohn K, Birkemeyer C. Glycerophosphoglycerol, beta-alanine, and pantothenic acid as metabolic companions of glycolytic activity and cell migration in breast cancer cell lines. Metabolites. 2013;3:1084–101.CrossRefPubMedPubMedCentral
Metadata
Title
Alteration of metabolite profiling by cold atmospheric plasma treatment in human myeloma cells
Authors
Dehui Xu
Yujing Xu
Ning Ning
Qingjie Cui
Zhijie Liu
Xiaohua Wang
Dingxin Liu
Hailan Chen
Michael G. Kong
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2018
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-018-0541-z

Other articles of this Issue 1/2018

Cancer Cell International 1/2018 Go to the issue

Primary research

An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma

Primary research

Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis

Review

Research progresses in roles of LncRNA and its relationships with breast cancer

Primary research

Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression

Primary Research

C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells

Primary research

Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits